波兰制药行业市场前景及投资研究报告-培训课件外文版2024.4赵一鸣_第1页
波兰制药行业市场前景及投资研究报告-培训课件外文版2024.4赵一鸣_第2页
波兰制药行业市场前景及投资研究报告-培训课件外文版2024.4赵一鸣_第3页
波兰制药行业市场前景及投资研究报告-培训课件外文版2024.4赵一鸣_第4页
波兰制药行业市场前景及投资研究报告-培训课件外文版2024.4赵一鸣_第5页
已阅读5页,还剩104页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

INDUSTRIES

&

MARKETSPharmaceuticalindustryinPolandCHAPTER

01OverviewValueofthepharmaceuticalmarketinPolandfrom2015to2023(inbillionzloty)ValueofthepharmaceuticalmarketinPoland2015-2023605050.4246.0640.584037.2363533323030201002015201620172018201920202021202220235Description:ThevalueofthepharmaceuticalmarketinPolandshowedanupwardtrend,reachingover50billionzlotyin2023,anincreaseof9.5percentcomparedtothepreviousyear.

ReadmoreNote(s):Poland;2015to2023Source(s):Cowzdrowiu.pl;GazetaPrawna;IQVIA;ISBZdrowie;NajwyzszaIzbaKontroli;PEXPharmaSequence;PolishAssociationofSelfMedicationIndustry;WirtualneMediaValueofthepharmacywholesalemarketinPolandfrom2017to2022(inbillionzloty)ValueofthepharmacywholesalemarketinPoland2017-202212109.969.689.739.679.089.138.738.388.348.118.047.947.887.947.817.59864207.527.237.217.197.077.066.876.18Q1'17Q2

'17Q3

'17Q4

'17Q1

'18Q2

'18Q3

'18Q4

'18Q1

'19Q2

'19Q3

'19Q4

'19Q1

'20Q2

'20Q3

'20Q4

'20Q1

'21Q2

'21Q3

'21Q4

'21Q1

'22Q2

'22Q3

'22Q4

'226Description:ThevalueofthepharmacywholesalemarketinPolandin2022increasedby13.9percentyear-on-year,reaching38.49billionzloty.ReadmoreNote(s):Poland;Q12017toQ42022Source(s):NEUCAValueofpharmacymarketsegmentsinPolandfrom2018to2022(inbillionzloty)ValueofpharmaciesmarketinPoland2018-2022,bysegmentIndependentpharmaciesChainpharmacies252020.9617.8617.5216.616.1515.9415.4415.4515.2214.71151050201820192020202120227Description:In2022,thechainpharmacymarketinPolandwasworth21billionzloty,3.4billionzlotymorethanthatofindependentpharmacies.Independentpharmacies'marketvalueincreasedby9.9percentcomparedtothepreviousyear.Incomparison,thegrowthrateforchainpharmaciesamountedto17.4percent.ReadmoreNote(s):Poland;2018to2022Source(s):IQVIA;NEUCAValueofsoldproductionofmedicamentsandotherpharmaceuticalproductsinPolandfrom2022to2023(in1,000zloty)ValueofsoldproductionofmedicamentsandotherpharmaceuticalsinPoland2022-2023ValueinthousandPLN202320222,000,000

4,000,000

6,000,000

8,000,000

10,000,00012,000,00014,000,000013,069,60411,519,277Medicamentscontainingalkaloidsortheirderivatives,butnotcontaininghormonesorantibiotics;othermedicaments594,970525,490Medicamentscontainingpenicillinsorotherantibiotics242,546212,744Adhesivedressingsorsimilararticles;impregnatedorcoatedwithpharmaceuticalsubstances;orputupinformsforretailsale67,462Wadding,gauze,etc.,withpharmaceuticalsubstances,p.r.s.,n.e.c.First-aidboxesandkits120,3535117148Description:DrugscontainingalkaloidsortheirderivativesaccountedforthelargestshareofsoldmedicamentsproductioninPoland,valuedatnearly13.1billionzlotyin2023.ReadmoreNote(s):Poland;2022to2023Source(s):CentralStatisticalOfficeofPolandConsumptionvalueofpharmaceuticalsinPolandfrom2018to2022(inbillioneuros)PharmaproductsconsumptioninPoland2018-2022987.77.77.47.37.176543210201820192020202120229Description:In2022,theconsumptionvalueofpharmaceuticalsinPolandamountedto7.7billioneurosandhasremainedstablesince2021.ReadmoreNote(s):Poland;2018to2022Source(s):CEFIC(ChemdataInternational);VCIAveragemonthlypercapitaexpenditureonmedicalandpharmaceuticalproductsinPolandfrom2019to2022(inzloty)PercapitaaveragemonthlyspendingonmedicalproductsinPoland2019-2022140120120.07109.41100.3195.65100806040200201920202021202210Description:Pole'sexpenditureonmedicalandpharmaceuticalproductsincreasedovertheperiodoftimeobserved.In2022,theconsumersspentover120zlotypermonthontheseproducts.

ReadmoreNote(s):Poland;2019to2022Source(s):CentralStatisticalOfficeofPolandRevenuesofcompaniesmanufacturingpharmaceuticalproductsinPolandfrom2015to2022(inmillionzloty)RevenuesofenterprisesproducingpharmaceuticalproductsinPoland2015-202225,00023,253.120,00018,237.917,77117,521.815,428.314,609.715,00010,0005,00008,042.9201520172018201920202021202211Description:Duringtheobservedperiod,therevenueofenterprisesproducingpharmaceuticalsinPolandfluctuated.In2022,theserevenuesamountedtoapproximately23.3billionzloty.

ReadmoreNote(s):Poland;2015to2022;Companieswith10andmoreemployeeesSource(s):CentralStatisticalOfficeofPolandNumberofcompaniesinthepharmaceuticalsectorinPolandfrom2005to2022NumberofcompaniesinthepharmaceuticalsectorinPoland2005-20226005004914874824114003783723503413303293032942813002001000261236212200520082009201020112012201320142015201620172018201920202021202212Description:ThenumberofpharmaceuticalcompaniesinPoland'spharmaceuticalsectorincreasedintheobservedperiod,reaching411entitiesin2022.ReadmoreNote(s):Poland;2005to2022Source(s):CentralStatisticalOfficeofPoland;EurostatNumberofemployeesinthepharmaceuticalsectorinPolandfrom2008to2022(in1,000s)NumberofemployeesinthepharmaceuticalsectorinPoland2008-20223027.926.32625.825.1424.2624.125201510523.923.623.4222.822.5122.3521.5821.58020082009201020112012201320142015201620172018201920202021202213Description:In2022,thepharmaceuticalsectorinPolandemployed28thousandpeople,anincreasefromthepreviousyear.ReadmoreNote(s):Poland;2008to2022;*AnnualaveragesReadmoreSource(s):CentralStatisticalOfficeofPolandSalarylevelsinpharmaceuticalsectorinPolandin2023(in1,000zloty)SalarylevelsinpharmaceuticalsectorinPoland2023ValueinthousandPLNMostfrequentlyofferedsalaryforagivenposition10Grossmonthlysalaryfortheposition(full-time)15

20

2505303533MedicalDirectorR&DDirectorBusinessUnitManagerCommercialDirector2727323220253028MarketAccessManagerMarketingManagerMultichannel&DigitalManagerQualityDirectorQualityControlManagerProductManager(innovation)ProducManagerRX(generics)MedicalAdvisor22252520201923181816.5171516142114Description:ThemostcommonsalaryofferedfortheMedicalAdvisorpositionwas21thousandzlotyamonthinPoland.APharmaceuticalRepresentativecouldcountonseventhousandzlotyamonthin2023.

ReadmoreNote(s):Poland;2023;employers,employees,andjobcandidatesSource(s):HaysPolandCHAPTER

02ManufacturingRevenuesfrompharmaceuticalproductsproductioninPolandfrom2005to2022(inmillionzloty)RevenuesfrompharmaceuticalproductsproductioninPoland2005-202225,00023,28320,00018,398.817,969.617,390.316,529.515,685.114,662.715,00010,0005,00009,333.42005201020152018201920202021202216Description:PharmaceuticalgoodsproductionrevenuesinPolandreachednearly23.3billionzlotyin2022,anincreasecomparedtothepreviousyear.

ReadmoreNote(s):Poland;2005to2022Source(s):CentralStatisticalOfficeofPolandProductionofpharmaceuticalsinPolandfrom2018to2023,bytypeofproduct(inmillionzloty)ProductionofpharmaceuticalsinPoland2018-2023,bytypeofproductBasicpharmaceuticalproducts16,000Medicamentsandotherpharmaceuticalpreparations15,04614,00012,00013,08211,54410,87810,6809,72910,0008,0006,0004,0002,000077661348935538142520182019202020212022202317Description:TheproductionofpharmaceuticalproductsiscontinuouslyincreasinginPoland.In2018,theproductionofmedicamentsandotherpharmaceuticalproductswasworthalmost10billionzloty;thisfigurehasalreadyrisentonearly13billionzlotyby2022.Atthesametime,thevalueofbasicpharmaceuticalproductsproducedalsoincreasedbyover300millionzloty.ReadmoreNote(s):Poland;2018to2023Source(s):CentralStatisticalOfficeofPolandProductionchangeofchemicalsandpharmaceuticalsinPolandfrom2017to2022ProductionchangeofchemicalsandpharmaceuticalsinPoland2017-202216%14%12%10%8%14.8%9.8%6%4.2%4%4%2%2.5%20200%-2%-4%-6%-3.2%2018201720192021202218Description:TheproductionvolumeofchemicalsandpharmaceuticalsinPolandin2022increasedbynearlytenpercentcomparedtothecorrespondingperiodofthepreviousyear.Thehighestwasrecordedin2021,atalmost15percent.

ReadmoreNote(s):Poland;2017to2022Source(s):VCISoldproductionofpharmaceuticalproductsinPolandfrom2015to2022(inmillionzloty)SoldproductionofpharmaceuticalproductsinPoland2015-202218,00015,702.516,00014,121.113,50514,00012,00010,0008,0006,0004,0002,000013,235.113,33712,666.511,526.311,2572015201620172018201920202021202219Description:SoldproductionofpharmaceuticalproductsinPolandfluctuatedintheobservedperiodandpeakedin2022.Thesaleswerethelowestin2018andamountedto11.2billionzloty.ReadmoreNote(s):Poland;2015to2022Source(s):CentralStatisticalOfficeofPolandManufactureofbasicpharmaceuticalproductsrevenueinPolandfrom2010to2022(inmillionU.S.dollars)ManufactureofbasicpharmaceuticalproductsrevenueinPoland2010-2022300283.66242.61240.425020015010050237.76234.95234.58230.77226.19220.7212.97202.94201.47189.0702010201120122013201420152016*2017*2018*2019*2020*2021*2022*20Description:ThisstatisticshowstherevenueofmanufactureofbasicpharmaceuticalproductsinPolandfrom2010to2015,withaforecastto2022.ItisprojectedthattherevenueofmanufactureofbasicpharmaceuticalproductsinPolandwillamounttoapproximately243millionU.S.dollarsby2022.ReadmoreNote(s):2010-2015;*Estimate-Thisalsoappliesforpastyearsasdataprovidedbystatisticalinstitutionsoftenisnotavailableformorerecentyears.TheindustryclassificationisbasedontheNACERev.2-systeminPoland.Theindustry[...]

ReadmoreSource(s):ManufactureofpharmaceuticalpreparationsrevenueinPolandfrom2010to2022(inmillionU.S.dollars)ManufactureofpharmaceuticalpreparationsrevenueinPoland2010-20226,0005,0005,427.275,353.425,261.125,145.755,001.534,821.264,595.914,360.084,233.83,910.913,842.144,0003,0002,0001,00003,591.513,356.452010201120122013201420152016*2017*2018*2019*2020*2021*2022*21Description:ThisstatisticshowstherevenueofmanufactureofpharmaceuticalpreparationsinPolandfrom2010to2015,withaforecastto2022.ItisprojectedthattherevenueofmanufactureofpharmaceuticalpreparationsinPolandwillamounttoapproximately5,427millionU.S.dollarsby2022.ReadmoreNote(s):2010-2015;*Estimate-Thisalsoappliesforpastyearsasdataprovidedbystatisticalinstitutionsoftenisnotavailableformorerecentyears.TheindustryclassificationisbasedontheNACERev.2-systeminPoland.Theindustry[...]

ReadmoreSource(s):VolumeofprovitaminsandvitaminsproductioninPolandfrom2015to2022(inmetrictons)VolumeofprovitaminsandvitaminsproductioninPoland2015-2022120,000100,00080,00060,00040,000100,23520,00010,33920218,44720199,02920207,55120186,1094,08720154,673201602017202222Description:Theproductionofprovitamins,vitamins,andtheirderivativesinPolandincreasedin2022,reachingover100.2thousandmetrictons.ReadmoreNote(s):Poland;2015to2022Source(s):CentralStatisticalOfficeofPolandProductionofantibioticsinPolandfrom2022to2023(inkilograms)ProductionofantibioticsinPoland2022-20232,5002,0532,0001,4361,5001,00050002022202323Description:TheproductionofantibioticsinPolanddecreasedcomparedtothepreviousyear,reaching1.4metrictonsin2023.ReadmoreNote(s):Poland;2022to2023Source(s):CentralStatisticalOfficeofPolandCHAPTER

03TradeForeigntradeinpharmaceuticalsubstancesinPolandfrom2015to2022(inbillioneuros)ForeigntradeinpharmaceuticalsubstancesinPoland2015-2022ExportImport1.21.111.00.80.60.40.20.00.90.90.70.70.60.60.40.40.30.30.30.20.20.12015201620172018201920202021202225Description:In2022,theexportvalueofpharmaceuticalsubstancesinPolandamountedto0.4billioneuros.However,themarketrecordedanegativetradebalance,reaching0.5billioneuros.

ReadmoreNote(s):Poland;2015to2022Source(s):BankPekaoSAForeigntradeindrugsandpharmaceuticalproductsinPolandfrom2015to2022(inbillioneuros)ForeigntradeindrugsandpharmaceuticalproductsinPoland2015-2022ExportImport1099.48.487.476.56.165432105.654.94.54.44.13.83.53.12.72.62015201620172018201920202021202226Description:In2022,theexportvalueofdrugsandpharmaceuticalproductsinPolandamountedtofivebillioneuros.However,themarketrecordedanegativetradebalance,reaching4.4billioneuros.

ReadmoreNote(s):Poland;2015to2022Source(s):BankPekaoSAImportvalueofpharmaceuticalproductsinPolandfrom2011to2022(inmillioneuros)ImportvalueofpharmaceuticalproductsinPoland2011-20229,0008,0007,0006,0005,0008,055.347,446.747,012.136,357.095,778.715,566.734,943.874,590.194,448.674,341.794,286.464,024.074,0003,0002,0001,000020112012201320142015201620172018201920202021202227Description:Overtheperiodobserved,totalimportsofpharmaceuticalproductsinPolandincreasedandreachedovereightbillioneurosin2022.ReadmoreNote(s):Poland;2011to2022;*ProductsareclassifiedaccordingtotheHarmonizedSystem(HS)codes.ThetwodigitHScodeoftheproductsdescribedinthisstatisticis30,underthenameof"Pharmaceuticalproducts".

ReadmoreSource(s):UNComtradeExportvalueofpharmaceuticalproductsinPolandfrom2011to2022(inmillioneuros)ExportvalueofpharmaceuticalproductsinPoland2011-20225,0004,5004,0003,5003,0004,386.993,843.863,540.883,453.83,246.092,902.582,788.112,701.552,638.372,368.092,5002,0001,5001,0005001,848.331,648.88020112012201320142015201620172018201920202021202228Description:Overtheperiodobserved,totalexportsofpharmaceuticalproductsinPolandincreasedandreachedover4.3eurosin2022.

ReadmoreNote(s):Poland;2011to2022;*ProductsareclassifiedaccordingtotheHarmonizedSystem(HS)codes.TwodigitHScodeoftheproductsdescribedinthisstatisticis30,underthenameof"Pharmaceuticalproducts".

ReadmoreSource(s):UNComtradeValueofpharmaceuticalproductsimportsinPolandfrom2021to2022,bycountryofdestination(inmillioneuros)ValueofimportofpharmaceuticalstoPoland2021-2022,bycountryImportvalueinmillioneuros2022800202102004006001,0001,2001,4001,6001,8001,530.14GermanyUSA1,330.641,111.92976510.2Ireland495.04504.39Italy393.57473.56465.59France364.66304.29HungarySwitzerlandNetherlandsDenmarkUK355.98343.1354241.55308.78262.69275.73279.9429Description:In2022,thevalueofpharmaceuticalimportstoPolandamountedto8.06billioneuros.ThehighestvaluewasimportedfromGermanyandamountedto1.5billioneuros.

ReadmoreNote(s):Poland;2021to2022Source(s):InternationalTradeCentreValueofpharmaceuticalsexportinPolandfrom2021to2022,bycountryofdestination(inmillioneuros)ValueofexportofpharmaceuticalsfromPoland2021-2022,bycountryExportvalueinmillioneuros202220214000100200300500600700800758.7GermanyRussiaFranceCzechiaUK528.28352.23285.47230.77218.25216.73193.54116.33115.69171.8Italy127.88179.3176.52173.56BelgiumHungarySpain61.2783.2798.88154.17143.95Denmark30Description:In2022,thevalueofpharmaceuticalsexportedfromPolandamountedto4.39billioneuros.ThehighestvaluewasexportedtoGermanyandamountedtonearly759millioneuros.

ReadmoreNote(s):Poland;2021to2022Source(s):InternationalTradeCentreImportvalueofthechemicalsandpharmaceuticalsindustryinPolandfrom2020to2022,bysegment(inbillioneuros)ChemicalsandpharmaimportvalueinPoland2020-2022,bysegment202020212022141210811.810.810.59.18.77.97.77.46.96.665.14.143.93.543.22.82.720PolymersPharmaceuticalsFineandspecialtychemicalsInorganicchemicalsPetrochemicalsandtheir

Cleaningandbodycarederivatives

products31Description:ImportsofpolymerstoPolandhadthehighestvalueamongothertypesofchemicalproducts,measuringnearly12billioneurosin2022.Thesecondleadingimportcommodityonthemarketwaspharmaceuticalproducts,with11billioneurosworthofsuchproductspurchasedbythePolishindustryfromabroad.Ontheotherhand,thevalueofchemicalandpharmaceuticalexportswerethehighestforfineandspecialtychemicals.ReadmoreNote(s):Poland;2020to2022Source(s):CEFIC(ChemdataInternational);VCIExportvalueofthechemicalsandpharmaceuticalsindustryinPolandfrom2020to2022,bysegment(inbillioneuros)ChemicalsandpharmaexportvalueinPoland2020-2022,bysegment2020202120228765432106.76.56.25.85.75.64.84.44.44.43.83.63.22.52.32.11.71.5FineandspecialtychemicalsCleaningandbodycareproductsPharmaceuticalsPolymersInorganicchemicalsPetrochemicalsandtheirderivatives32Description:ExportsoffineandspecialtychemicalsfromPolandearnedthehighestvalueamongotherchemicalsandpharmaceuticals,measuring6.7billioneurosin2022.Thesecondleadingexportcommodityonthemarketwascleaningandbodycareproducts,with6.5billioneurosworthofsuchproductssoldfromPolandabroad.Asaresult,thetotalvalueofexportsinPoland'schemicalandpharmaceuticalindustryamountedto30.3billioneurosin2022,anincreaseoverthepreviousyear.

ReadmoreNote(s):Poland;2020to2022Source(s):CEFIC(ChemdataInternational);VCICHAPTER

04SalesShareofpeoplepurchasingmedicineanddietarysupplementsonlineinPolandfrom2020to2023ShareofpeoplebuyingmedicineanddietarysupplementsonlineinPoland2020-202318%16.8%16%14%12%10%8%15.1%14.3%14.2%6%4%2%0%202020212022202334Description:In2023,nearly17percentofPoleswhobuymedicineordietarysupplementsregularlyusedtheonlinechannelforthispurpose.ReadmoreNote(s):Poland;2020to2023;Individualsorderingorpurchasingovertheinternetinthelast3monthsSource(s):CentralStatisticalOfficeofPolandSalesstructureinthepharmacymarketinPolandfrom2021to2023SalesstructureinthepharmacymarketinPoland2021-2023ReimbursedprescriptionsFull-payprescriptionsOTCOther120%100%80%60%40%20%0%202120222023*35Description:Salesofover-the-counterproducts,suchasOTCdrugs,dietarysupplements,herbalproducts,cosmetics,andothers,accountedforthelargestshareofsalesinthepharmacymarketinPolandduringtheobservedperiod.

ReadmoreNote(s):Poland;2021to2023;*ForecastFigurescalculatedbySource(s):GrantThornton;basedonthedataprovidedbythesourceReadmoreTotalpharmacymarketsalesinPolandfrom2019to2023(inmillionzloty)TotalpharmacymarketturnoverinPoland2019-2023TotalsalesRxreimbursed*Rxnonreimbursed**NonRxproducts***46,05660,00050,00040,00030,00020,00010,000050,41840,57737,70737,17221,90620,34417,30116,5628,44715,91914,54613,50013,47912,66012,39812,78211,79710,1568,3072019202020212022202336Description:In2023,thepharmacymarketinPolandrecordedsalesof50billionzloty,increasingby9.5percentcomparedtothepreviousyear.

ReadmoreNote(s):Poland;2019to2023;*TotalsalesofRxproductscoveredbyNHFreimbursement**TotalsalesofRxproductsnotcoveredbyNHFreimbursement***Totalsalesofproductsavailablewithoutprescription,includingOTCmedicines,food[...]

ReadmoreSource(s):PEXPharmaSequenceValueofreimburseddrugsalesinPolandfrom2019to2023(inmillionzloty)ValueofreimburseddrugsalesinPoland2019-202316,00014,54613,50014,00012,66012,78212,39812,00010,0008,0006,0004,0002,00002019202020212022202337Description:In2023,thevalueofreimburseddrugsalesinPolandamountedtoover14.5billionzloty,increasingby7.7percentcomparedtothepreviousyear.

ReadmoreNote(s):Poland;2019to2023;*TotalsalesofRxproductscoveredbyNHFreimbursementReadmoreSource(s):PEXPharmaSequenceValueofnon-reimburseddrugsalesinPolandfrom2019to2023(inmillionzloty)Valueofnon-reimburseddrugsalesinPoland2019-202316,00014,00012,00013,47911,79710,15610,0008,3078,0008,4476,0004,0002,00002019202020212022202338Description:In2023,thevalueofnon-reimburseddrugsalesinPolandamountedtoover13.4billionzloty,increasingby14.3percentcomparedtothepreviousyear.

ReadmoreNote(s):Poland;2019to2023;*TotalsalesofRxproductsnotcoveredbyNHFreimbursementReadmoreSource(s):PEXPharmaSequenceValueofsalesofreimbursedmedicinesinPolandfrom2021to2023(inmillionzloty)ValueofsalesofreimbursedmedicinesinPoland2021-202316,00014,00012,00010,0008,0006,0004,0002,0000202120222023*39Description:ThesalesvalueofreimbursedmedicinesinPolandincreasedby5.6percentannuallyin2022,reachingover13.5billionzloty.ReadmoreNote(s):Poland;2021to2023;*ForecastReadmoreSource(s):GrantThorntonValueofprescriptionmedicinessalesinPolandin2022,byanatomicalgroups(ATC)(inmillionzloty)ValueofprescriptionmedicinessalesinPoland2022,byATCSalesvalueinmillionzloty1,000

1,500

2,00005002,5003,0003,5004,0004,5005,000Cardiovascular-relatedmedicinesGastrointestinaltractandmetabolismCentralnervoussystemBloodandhematopoieticsystemRespiratorysystemGenitourinarysystemandsexhormonesAnti-infectivesMusculoskeletalsystemAnticancerandimmunomodulatorymedicinesDermatologyOrgansofvisionandhearingHormonalmedicinesforinternaluseAntiparasiticmedicines,insecticidesOther40Description:ThevalueofprescriptionmedicinessalesinPolandamountedtonearly21.9billionzlotyin2022.Cardiovascular-relatedmedicineshadthehighestshareinsalesofallprescriptionmedicinesinPolandin2022.Thedigestivetractandmetabolismdrugsfollowedthem.ReadmoreNote(s):Poland;2022Source(s):CentralStatisticalOfficeofPoland;Centrume-Zdrowia;SalesvalueofsleepproductinPolandfrom2002to2024(inmillionzloty)SleepproductsalesvalueinPoland2002-20244003503002502001501005002002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023*

2024*41Description:Intheobservedperiod,thevalueofsleepproductssalesinPolandincreasedby66percent,amountingto315.6millionzlotyin2022.In2024,thevalueofsleepproductsaleswasforecastedtoincreasebyaroundninepercent.

ReadmoreNote(s):Poland;2002to2022Source(s):OgólnopolskiSystemOchronyZdrowiaSalesvalueofantidepressantsinPolandfrom2002to2024(inmillionzloty)AntidepressantssalesvalueinPoland2002-20241,00090080070060050040030020010002002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023*

2024*42Description:Intheobservedperiod,thevalueofantidepressantsalesinPolandincreasedbyaround74percent,amountingto751.1millionzlotyin2022.In2024,thevalueofantidepressantssaleswasforecastedtoincreasebyaround14percent.

ReadmoreNote(s):Poland;2002to2022Source(s):OgólnopolskiSystemOchronyZdrowiaSalesvalueofantibioticsinPolandfrom2002to2024(inbillionzloty)AntibioticssalesvalueinPoland2002-20241.61.41.21.00.80.60.40.20.02002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023*

2024*43Description:Intheobservedperiod,thevalueofantibioticssalesinPolandincreasedby19percent,amountingto1.28billionzlotyin2022.Thevalueofantibioticssaleswasforecastedtoincreasebyaround11percentby2024.

ReadmoreNote(s):Poland;2002to2022Source(s):OgólnopolskiSystemOchronyZdrowiaCHAPTER

05Products&pricesRevenueofthevitamins&mineralsmarketinPolandfrom2019to2028(inmillionU.S.dollars)Revenueofthevitamins&mineralsindustryinPoland2019-2028900800700825.8781.05736.3691.55649.83611.53575.646005004003002001000541.83512.34487201920202021202220232024202520262027202845Description:Therevenueinthe'Vitamins&Minerals'segmentoftheOTCpharmaceuticalsmarketinPolandwasforecasttocontinuouslyincreasebetween2023and2028byintotal214.3millionU.S.dollars(+35.04percent).Aftertheninthconsecutiveincreasingyear,theindicatorisestimatedtoreach825.8millionU.S.dollarsandthereforeanewpeakin2028.Notably,therevenueofthe'Vitamins&Minerals'segmentoftheOTCpharmaceuticalsmarketwascontinuouslyincreasingoverthe[...]

ReadmoreNote(s):Poland;2019to2028Source(s):HealthMarketInsightsRevenueofthecold&coughremediesmarketinPolandfrom2019to2028(inmillionU.S.dollars)Revenueofthecold&coughremediesindustryinPoland2019-20281,8001,6001,4001,2001,0008006004002000201920202021202220232024202520262027202846Description:Therevenueinthe'Cold&CoughRemedies'segmentoftheOTCpharmaceuticalsmarketinPolandwasforecasttocontinuouslyincreasebetween2023and2028byintotal590.5millionU.S.dollars(+56.67percent).Aftertheeighthconsecutiveincreasingyear,theindicatorisestimatedtoreach1.6billionU.S.dollarsandthereforeanewpeakin2028.ReadmoreNote(s):Poland;2019to2028Source(s):HealthMarketInsightsRevenueoftheanalgesicsmarketinPolandfrom2019to2028(inmillionU.S.dollars)RevenueoftheanalgesicsindustryinPoland2019-20281,2001,0001,134.141,038.56942.98852.61764.64800693.86621.89598.52600400200052

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论